For research use only. Not for therapeutic Use.
hGPR91 antagonist 3 (Compound 5g) is a potent and orally active GPR91 antagonist with IC50 of 35 nM and 135 nM, for human GPR91 and rat GPR91, respectively[1].
| Catalog Number | I043971 |
| CAS Number | 1314796-31-0 |
| Synonyms | N-[[3-[4-fluoro-3-(trifluoromethyl)phenyl]-1,2-oxazol-5-yl]methyl]-4-(1,8-naphthyridin-2-yl)butanamide |
| Molecular Formula | C23H18F4N4O2 |
| Purity | ≥95% |
| InChI | InChI=1S/C23H18F4N4O2/c24-19-9-7-15(11-18(19)23(25,26)27)20-12-17(33-31-20)13-29-21(32)5-1-4-16-8-6-14-3-2-10-28-22(14)30-16/h2-3,6-12H,1,4-5,13H2,(H,29,32) |
| InChIKey | SWKGPCNQBPGWNX-UHFFFAOYSA-N |
| SMILES | C1=CC2=C(N=C1)N=C(C=C2)CCCC(=O)NCC3=CC(=NO3)C4=CC(=C(C=C4)F)C(F)(F)F |
| Reference | [1]. Bhuniya D, et al. Discovery of a potent and selective small molecule hGPR91 antagonist. Bioorg Med Chem Lett. 2011;21(12):3596-3602. |
